Boston Immune Technologies & Therapeutics Inc

Boston Immune Technologies And Therapeutics, Inc. develops antibody therapeutics within the biotechnology industry. The Company advances clinical immunotherapies for cancer and autoimmune diseases, and conducts research on TNFR superfamily antagonism. Boston Immune Technologies & T serves pharmaceutical companies, healthcare providers, and research institutions in the United States.